Prokarium
- Biotech or pharma, therapeutic R&D
Prokarium is a UK biotech company with a lead program in phase 1 clinical development in the US for non-muscle invasive bladder cancer (NMIBC). By combining cutting-edge synthetic biology with AI-enabled discovery, the company creates next generation bacterial immunotherapies.
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
){kind=logo}